EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pharmaceutical Stocks To Watch Today - August 16th - Markets Daily
Best Healthcare Stocks To Follow Today - August 16th - Markets Daily
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year
Top Biotech Stocks To Watch Now - August 16th - Stock Observer
Mirae Asset Global Investments Co. Ltd. Has $124.56 Million Stock Holdings in AbbVie Inc. $ABBV
Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV
RWQ Financial Management Services Inc. Acquires 31,510 Shares of AbbVie Inc. $ABBV
Campbell Newman Asset Management Inc. Sells 10,481 Shares of AbbVie Inc. $ABBV
SOA Wealth Advisors LLC. Lowers Stock Holdings in AbbVie Inc. $ABBV
SOA Wealth Advisors LLC. Sells 13,215 Shares of AbbVie Inc. $ABBV
Top Biotech Stocks To Follow Now - August 15th - Daily Political
AbbVie Inc. $ABBV Stake Boosted by Envestnet Portfolio Solutions Inc.
2 Reasons to Like ABBV and 1 to Stay Skeptical
AbbVie Defends Its Turf, But Leaves One Big Question Open
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Top Pharmaceutical Stocks Worth Watching - August 14th - Stock Observer
SCHD vs. HDV: Which Dividend ETF Is the Better Buy for Investors?
Gateway Investment Advisers LLC Sells 13,696 Shares of AbbVie Inc. $ABBV
Thomasville National Bank Buys Shares of 26,575 AbbVie Inc. $ABBV
Clarity Financial LLC Has $50.02 Million Stock Position in AbbVie Inc. $ABBV
Farmers & Merchants Investments Inc. Acquires 3,498 Shares of AbbVie Inc. $ABBV - Zolmax
Webster Bank N. A. Sells 2,782 Shares of AbbVie Inc. $ABBV - Stock Observer
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Johnson & Johnson (JNJ)'s $5.5B Talc Settlement: Turning Point or Temporary Relief?
AbbVie (NYSE:ABBV) Price Target Raised to $247.00 - Daily Political
Could AbbVie Inc. (ABBV)'s Post-Humira Transformation Drive the Next Phase of Growth?
Biogen (BIIB) and AbbVie (ABBV) Receive Rare Double Upgrades: What Investors Need to Know
Pharmaceutical Stocks To Follow Today - August 13th - Stock Observer
Here Are Thursday's Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
Harmony Asset Management LLC Boosts Holdings in AbbVie Inc. $ABBV - Zolmax
Moody Lynn Lieberson & Walker LLC Has $42.52 Million Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Acquired by Mission Wealth Management LP
Biotech Stocks To Consider - August 13th - Daily Political
Riverchase Wealth Management LLC Buys New Position in AbbVie Inc. $ABBV - Daily Political
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield
The Energy and Pharma Giants Quietly Funding HDV's 3% Yield, and How Safe Each One Is
Top Biotech Stocks To Watch Now - August 12th - Stock Observer
PEOPLE's 100 Companies That Care in 2026
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
AbbVie Inc. $ABBV Shares Bought by Wedge Capital Management L L P NC
Tema ETFs LLC Acquires 3,956 Shares of AbbVie Inc. $ABBV - Markets Daily
Tema ETFs LLC Purchases 3,956 Shares of AbbVie Inc. $ABBV - Zolmax
Cardinal Capital Management Inc. Buys 21,206 Shares of AbbVie Inc. $ABBV
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
BNP Paribas Exane Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
Eli Lilly Beat Big and Raised Guidance. Wall Street Sees More Room to Run
FY2027 EPS Estimates for AbbVie Lowered by Erste Group Bank
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
AbbVie Inc. $ABBV Position Cut by Handelsbanken Fonder AB
Drugs that missed the mark in pharma's last earnings round
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices | INN
KMG Fiduciary Partners LLC Cuts Stake in AbbVie Inc. $ABBV
E. Ohman J or Asset Management AB Buys 2,250 Shares of AbbVie Inc. $ABBV - Markets Daily
KMG Fiduciary Partners LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer
Carolina Wealth Advisors LLC Purchases 7,626 Shares of AbbVie Inc. $ABBV
Generali Investments Management Co LLC Buys 2,671 Shares of AbbVie Inc. $ABBV - Stock Observer
Carolina Wealth Advisors LLC Buys 7,626 Shares of AbbVie Inc. $ABBV - Stock Observer
AbbVie Inc. $ABBV Stock Holdings Reduced by Handelsbanken Fonder AB - Daily Political
Big pharma sues to block Illinois drug discount law
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
AbbVie's (ABBV) Botox Just Got A Step Closer To A Fifth Use
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
Sionna cystic fibrosis drug fails key trial, removing threat to Vertex
3 Beaten-Down Healthcare Stocks to Buy in August
Sapient Capital LLC Sells 8,705 Shares of AbbVie Inc. $ABBV
Promising Pharmaceutical Stocks To Watch Now - August 10th - Daily Political
Biotech Stocks To Keep An Eye On - August 10th - Daily Political
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages
Promising Pharmaceutical Stocks To Follow Now - August 9th - Markets Daily
GoalVest Advisory LLC Sells 6,171 Shares of AbbVie Inc. $ABBV
Cardano Risk Management B.V. Buys 32,345 Shares of AbbVie Inc. $ABBV
Agate Pass Investment Management LLC Has $13.67 Million Stock Position in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Stock Price Down 1% - Here's What Happened - Zolmax
Healthcare Stocks To Consider - August 8th - Stock Observer
Biotech Stocks To Watch Now - August 8th - Stock Observer
MRA Advisory Group Purchases 5,215 Shares of AbbVie Inc. $ABBV
MRA Advisory Group Boosts Position in AbbVie Inc. $ABBV - Stock Observer
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma
Exploring the mixed marketing authorisation pathway: a case study in ophthalmology
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed
Latest news
Show more
Gold Price Today, August 17: XAU/USD Rises 0.5% Towards $4,400 as Fed Hike Bets Fade
SK Hynix Stock Surges 20.6% as Memory Rally Lifts Micron and SanDisk
Alibaba Earnings Date Is August 20: Can Its AI Cloud Boom Outrun the Profit Squeeze?
AI Cloud Stocks Rally After Earnings as CoreWeave Gains 19% and Nebius Jumps 34%
US Dollar Index Slides Toward 99.50 as Weak Retail Sales Cut Fed Hike Bets
